[Comments on the guidelines of the European Society of Cardiology Task Force on pulmonary embolism].
Zonzin
P
P
Divisione di Cardiologia, Ospedale Civile, Viale Tre Martiri, 140 45100 Rovigo. zonzin@tin.it
Agnelli
G
G
Casazza
F
F
Favretto
G
G
Giuntini
C
C
Morpurgo
M
M
Vizza
C D
CD
D000792:Angiography; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016638:Critical Illness; D004452:Echocardiography; D017128:Embolectomy; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis / Q000628:therapy; D011336:Probability; D011446:Prospective Studies; D011644:Puerperal Disorders / Q000175:diagnosis / Q000628:therapy; D011651:Pulmonary Artery / Q000000981:diagnostic imaging; D011655:Pulmonary Embolism / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000628:therapy*; D011877:Radionuclide Imaging; D012307:Risk Factors; D012680:Sensitivity and Specificity; D013923:Thromboembolism / Q000517:prevention & control; D015912:Thrombolytic Therapy; D014057:Tomography, X-Ray Computed; D016306:Vena Cava Filters
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin